Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Haloperidol
Pinewood Healthcare
N05AD01
Haloperidol
2mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100; GTIN: 5099186001357 5099186001425
23LF01493PW 23LF01493PW Driving and using machines Haloperidol can affect your ability to drive and use tools or machines. Side effects, such as feeling sleepy, may affect your alertness, particularly when you first start taking it or after a high dose. Do not drive or use any tools or machines without discussing this with your doctor first. Haloperidol contains methylhydroxybenzoate and propylhydroxybenzoate • Methylhydroxybenzoate (E218) and propylhydroxybenzoate (E216): may cause allergic reactions (possibly delayed). 3. HOW TO TAKE HALOPERIDOL Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. How much should you take Your doctor will tell you how much Haloperidol to take and for how long. Your doctor will also tell you whether to take Haloperidol one or more times a day. It may be some time before you feel the full effect of the medicine. Your doctor will normally give you a low dose to start, and then adjust the dose to suit you. It is very important you take the correct amount. Your dose of haloperidol will depend on: • your age • what conditions you are being treated for • whether you have problems with your kidneys or liver • other medicines you are taking. Adults • Your dose will normally be between 0.5 mg and 10 mg each day. • Your doctor may adjust this to find the dose that suits you best. • The highest dose adults should take depends on the condition you are being treated for and varies between 5 mg and 20 mg each day. Elderly people • Elderly people will normally start on 0.5 mg each day or half the lowest adult dose. • The amount of Haloperidol you take will then be adjusted until the doctor finds the dose that suits you best. • The highest dose elderly people should take is 5 mg each day unless your doctor decides a higher dose is needed. Children and adolescents 6 to 17 years of age • Your dose will normally be between 0.5 mg and 3 mg each day. • Adolescents up to 17 years of age being t Read the complete document
OBJECT 1 HALOPERIDOL ORAL SOLUTION BP 10 MG/5 ML Summary of Product Characteristics Updated 13-Mar-2018 | Pinewood Healthcare 1. Name of the medicinal product Haloperidol Oral Solution BP 10 mg/5 ml 2. Qualitative and quantitative composition Each 5 ml contains 10 mg of Haloperidol For the full list of excipients, see section 6.1. 3. Pharmaceutical form Oral Solution 4. Clinical particulars 4.1 Therapeutic indications Adult patients aged 18 years and above • Treatment of schizophrenia and schizoaffective disorder. • Acute treatment of delirium when non-pharmacological treatments have failed. • Treatment of moderate to severe manic episodes associated with bipolar I disorder. • Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder. • Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer's dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others. • Treatment of tic disorders, including Tourette's syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed. • Treatment of mild to moderate chorea in Huntington's disease, when other medicinal products are ineffective or not tolerated. Paediatric patients Treatment of: • Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated. • Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • Tic disorders, including Tourette's syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed. 4.2 Posology and method of administration Posology _Adults _ A low initial dose is recommended, which subsequently may be adjusted acco Read the complete document